TQB3473, a novel spleen tyrosine kinase inhibitor for primary immune thrombocytopenia: a single-arm, open-label, multicenter phase 1 study

Journal of Thrombosis and Haemostasis · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles